Stock 002099 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Hisoar Pharmaceutical Co., Ltd.

Equities

002099

CNE000001PY2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
5.93 CNY -0.50% Intraday chart for Zhejiang Hisoar Pharmaceutical Co., Ltd. +7.62% -17.52%
Apr. 28 Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Hisoar Pharma's Unit Passes German Health Regulator's Inspection MT

Business Summary

ZHEJIANG HISOAR PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the manufacture and sale of pharmaceutical materials and dyes. The Company operates through two segments: Pharmaceutical segment and Dye segment. Pharmaceutical segment manufactures and sells Active Pharmaceutical Ingredients (APIs) and preparations, as well as provides customized production and supporting research and development services for international pharmaceutical companies. The Company’s pharmaceutical products comprise antibiotic series, hypoglycemic series and cardiovascular series. Dye segment is mainly involved in the manufacture and sale of environmentally friendly reactive dyes, dye intermediates and pigment intermediates. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 2,788

Sales per Business

CNY in Million2021Weight2022Weight Delta
Pharmaceutical
71.0 %
1,529 61.5 % 1,920 71.0 % +25.53%
Dye
29.1 %
977 39.3 % 788 29.1 % -19.39%
Intersegment Elimination
-1.9 %
-74 -3.0 % -52 -1.9 % -29.56%
Others
1.6 %
45 1.8 % 43 1.6 % -4.51%
Other Business
0.2 %
8 0.3 % 6 0.2 % -20.00%

Sales per region

CNY in Million2021Weight2022Weight Delta
Abroad
54.8 %
1,371 55.2 % 1,482 54.8 % +8.15%
China
45.2 %
1,114 44.8 % 1,222 45.2 % +9.66%

Managers

Managers TitleAgeSince
Guo Rui Xu CEO
 Chief Executive Officer 47 99-12-31
Bing Yao DFI
 Director of Finance/CFO 42 19-11-12
Jin Yun Hu BRD
 Director/Board Member 51 99-07-31
Hong Tao BRD
 Director/Board Member 51 22-11-29
Xiao Yang Wang BRD
 Director/Board Member 37 20-12-31
Ru Dong Jiang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Wei Zhong Gong BRD
 Director/Board Member 58 07-06-30
Guo Rui Xu CEO
 Chief Executive Officer 47 99-12-31
Bing Yao DFI
 Director of Finance/CFO 42 19-11-12
Minjie Chen CHM
 Chairman 56 -
Yang Chao Wang CHM
 Chairman 37 21-12-18
Xiao Yang Wang BRD
 Director/Board Member 37 20-12-31
Hong Tao BRD
 Director/Board Member 51 22-11-29
Yong Ping Yu BRD
 Director/Board Member 59 23-01-30
Jian Min Qian BRD
 Director/Board Member 66 23-01-30
Chao Liang BRD
 Director/Board Member 36 23-01-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,618,715,253 834,127,703 ( 51.53 %) 0 51.53 %

Shareholders

NameEquities%Valuation
Yun Fu Wang
40.38 %
642,782,587 40.38 % 498 M ¥
Sui Kai Lin
2.301 %
36,632,199 2.301 % 28 M ¥
Zhejiang Hisoar Pharmaceutical Co. Ltd. Esop
2.105 %
33,509,188 2.105 % 26 M ¥
Shanghai CR Asset Management Co., Ltd.
1.696 %
27,000,000 1.696 % 21 M ¥
Zhifeng Xiang
1.607 %
25,580,489 1.607 % 20 M ¥
Qin Yi Li
1.040 %
16,561,959 1.040 % 13 M ¥
Sheng Tong Lin
0.8736 %
13,906,078 0.8736 % 11 M ¥
Su Jun Wang
0.8531 %
13,578,800 0.8531 % 11 M ¥
Yinhua Fund Management Co., Ltd.
0.5614 %
8,936,248 0.5614 % 7 M ¥
GF Fund Management Co., Ltd.
0.2781 %
4,426,930 0.2781 % 3 M ¥

Company contact information

Zhejiang Hisoar Pharmaceutical Co., Ltd.

100, Waisha Branch Road Jiaojiang District

318000, Taizhou

+86 576 8908 8166

http://www.hisoar.com
address Zhejiang Hisoar Pharmaceutical Co., Ltd.(002099)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. Stock Zhejiang Hisoar Pharmaceutical Co., Ltd.
-17.52% 1.32B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002099 Stock
  4. Company Zhejiang Hisoar Pharmaceutical Co., Ltd.